July 10, 2020
Article
Polygenic risk scores, which evaluate disease risk based on DNA variants, have previously been based almost entirely on patients who had European ancestry.
July 02, 2020
Article
Applicants should show how they would measure biosimilars use and safety in both academic and community practice settings.
June 25, 2020
Article
The savings occurred even while more patients in the health system were enrolling in clinical trials, according to an abstract presented during the American Society of Clinical Oncology 2020 Virtual meeting.
June 20, 2020
Video
Using electronic health records of patients with cancer can provide a better understanding of which interventions and treatments are possible and can give patients the best outcomes, explained Blythe Adamson, PhD, MPH, principal quantitative scientist at Flatiron Health, in an interview for ASCO20 Virtual, this year’s annual meeting of the American Society of Clinical Oncology.
June 18, 2020
Article
Administrator Seema Verma said the proposal would create opportunities "for drug manufacturers to have skin in the game through payment arrangements that challenge them to put their money where their mouth is."
June 13, 2020
Article
Researchers warned that financial incentives that focus on a percentage of pathway compliance could “paradoxically harm the quality of care."
June 12, 2020
Article
Three abstracts presented at this year’s annual meeting of the American Society of Clinical Oncology focused on cardiotoxic effects of cancer treatment and how cardiac disease remains a barrier to effective cancer therapy among patients with cancer and survivors.
June 03, 2020
Article
CMS Administrator Seema Verma announced the update today in a blog post in Health Affairs.
May 30, 2020
Article
Debra A. Patt, MD, MPH, MBA, a breast cancer specialist at Texas Oncology is the lead author on the study being presented at ASCO.